comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 08:39:39 - browse：84

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Johnson & Johnson sues to stop Medicare negotiation

hotspot

knowledge

WSS

Why are elite athletes different? Take a look at their microbes

Johnson & Johnson sues to stop Medicare negotiation

Gene therapy has helped boys walk. Can scientists keep it that way?

Death of patient in Alzheimer’s trial raises question of possible risks

CDC concerned about possible undetected monkeypox spread in U.K.

US soldier in North Korean custody after crossing DMZ line

hotspot

comprehensive

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Biden administration sends mixed signals on US soldier who crossed into North Korea

As demand for Covid shots wanes, Moderna seeks its next success

Weight bias in eating disorder treatment complicated by new weight loss drugs

After affirmative action ruling, medical educators look to 'holistic review'

A look at other Americans who have crossed into North Korea over the years

Wildfire smoke exposes gaps in outdoor worker protections

Cloning humans is technically possible. It's curious no one has tried

Psychedelics group wrestles with new pharma identity

What would happen to your eyes if you looked at the solar eclipse?

hotspot

Twill hunts for pharma partner to market its depression app

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

STAT's guide to the next generation of CAR

3 hurdles to bringing medical devices to the U.S. market

Do masks work? RCTs can't tell us

New guidelines on severe brain injury complicate already difficult decisions

leisure time

hotspot

knowledge

focus